新诊断的冒烟型骨髓瘤和结直肠癌患者免疫性血小板减少症的管理
Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancer.
作者信息
Siniscalchi Agostina, Stasi Roberto, Fratoni Stefano, de Fabritiis Paolo, Caravita Tommaso
机构信息
S Eugenio Hospital, Department of Hematology, Piazzale le dell'Umanesimo, 10, Rome, 00144, Italy.
出版信息
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.03.2009.1715. Epub 2009 Jun 11.
Abstract
Immune thrombocytopoenia (ITP) is one of the most common autoimmune manifestations of B cell lymphoproliferative diseases. The association with multiple myeloma (MM) and solid tumours is rare. Here, a case of ITP associated with asymptomatic multiple myeloma and colon carcinoma, refractory to standard therapy and responsive to rituximab, is described. ITP should be considered in the differential diagnosis of thrombocytopoenia in MM and colon cancer. Understanding of the potential risk and reversibility of ITP should aid in the management of these patients.
摘要
免疫性血小板减少症（ITP）是B细胞淋巴增殖性疾病最常见的自身免疫表现之一。与多发性骨髓瘤（MM）和实体瘤相关的情况较为罕见。在此，描述了1例与无症状性多发性骨髓瘤和结肠癌相关的ITP病例，该病例对标准治疗无效，但对利妥昔单抗有反应。在MM和结肠癌患者血小板减少症的鉴别诊断中应考虑ITP。了解ITP的潜在风险和可逆性应有助于这些患者的管理。
相似文献
1
Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancer.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.03.2009.1715. Epub 2009 Jun 11.
2
Multiple myeloma with concurrent immune thrombocytopenic purpura.
Ecancermedicalscience. 2020 Feb 20;14:1012. doi: 10.3332/ecancer.2020.1012. eCollection 2020.
3
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
4
Controversies in the treatment of immune thrombocytopenia.
Curr Opin Hematol. 2016 Sep;23(5):479-85. doi: 10.1097/MOH.0000000000000270.
5
Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Blood Coagul Fibrinolysis. 2016 Jun;27(4):431-5. doi: 10.1097/MBC.0000000000000488.
6
Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Mayo Clin Proc. 2003 Nov;78(11):1340-6. doi: 10.4065/78.11.1340.
7
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9.
8
Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
BMC Nephrol. 2018 Mar 20;19(1):69. doi: 10.1186/s12882-018-0868-7.
9
Multiple myeloma developing during long-term clinical course of refractory immune thrombocytopenic purpura: a case report and review of literature.
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15429-32. eCollection 2015.
10
Multiple myeloma and immune thrombocytopenia.
Clin Lab Haematol. 2000 Aug;22(4):239-42. doi: 10.1046/j.1365-2257.2000.00125.x.
引用本文的文献
1
Can you Diagnose Immune Thrombocytopenia in Myeloma? A Case of Thrombocytopenia in a Patient with Multiple Myeloma.
Eur J Case Rep Intern Med. 2024 Nov 11;11(12):004981. doi: 10.12890/2024_004981. eCollection 2024.
2
Multiple myeloma with concurrent immune thrombocytopenic purpura.
Ecancermedicalscience. 2020 Feb 20;14:1012. doi: 10.3332/ecancer.2020.1012. eCollection 2020.
本文引用的文献
1
Pathobiology of secondary immune thrombocytopenia.
Semin Hematol. 2009 Jan;46(1 Suppl 2):S2-14. doi: 10.1053/j.seminhematol.2008.12.005.
2
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
Blood. 2009 Mar 12;113(11):2386-93. doi: 10.1182/blood-2008-07-162503. Epub 2008 Nov 12.
3
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Eur J Haematol. 2008 Sep;81(3):165-9. doi: 10.1111/j.1600-0609.2008.01100.x. Epub 2008 May 27.
4
Other immune thrombocytopenias.
Semin Hematol. 2007 Oct;44(4 Suppl 5):S24-34. doi: 10.1053/j.seminhematol.2007.11.004.
5
Current options for the treatment of idiopathic thrombocytopenic purpura.
Semin Hematol. 2007 Oct;44(4 Suppl 5):S12-23. doi: 10.1053/j.seminhematol.2007.11.003.
6
Secondary immune thrombocytopenic purpura.
Curr Opin Hematol. 2007 Sep;14(5):557-73. doi: 10.1097/MOH.0b013e3282ab9904.
7
Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.
Br J Haematol. 2007 Jul;138(2):249-52. doi: 10.1111/j.1365-2141.2007.06633.x. Epub 2007 May 29.
8
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
N Engl J Med. 2006 Oct 19;355(16):1672-81. doi: 10.1056/NEJMoa054626.
9
Autoimmune complications of chronic lymphocytic leukemia.
Semin Oncol. 2006 Apr;33(2):230-9. doi: 10.1053/j.seminoncol.2006.01.011.
10
The pattern of cytokine gene expression in human colorectal carcinoma.
Pathol Oncol Res. 2004;10(2):109-16. doi: 10.1007/BF02893465. Epub 2004 Jun 9.
Zotero 插件